Trial Profile
A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2022
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 10 Apr 2017 New trial record